7
Views
0
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Circulating antiretinal autoantibodies and age-related macular degeneration: what is the link?

&
Pages 27-31 | Published online: 09 Jan 2014

References

  • Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Grus FH. Analysis of IgG antibody patterns against retinal antigens and antibodies to α-crystallin, GFAP, and α-enolase in sera of patients with “wet” age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. DOI: 10.1007/s00417-006-0429-9 (2006).
  • Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog. Retin. Eye Res.20, 385–414 (2001).
  • Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res.20, 705–732 (2001).
  • Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science308, 419–421 (2005).
  • Hageman GS, Anderson DH, Johnson LV et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl Acad. Sci. USA102, 7227–7232 (2005).
  • Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science308, 385–389 (2005).
  • Okamoto H, Umeda S, Obazawa M et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol. Vis.12, 156–158 (2006).
  • Sepp T, Khan JC, Thurlby DA et al. Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest. Ophthalmol. Vis. Sci.47, 536–540 (2006).
  • Gold B, Merriam JE, Zernant J et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet.38, 458–462 (2006).
  • Chant SM, Heckenlively J, Meyers-Elliott RH. Autoimmunity in hereditary retinal degeneration. I. Basic studies. Br. J. Ophthalmol.69, 19–24 (1985).
  • Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol.228, 270–274 (1990).
  • Gurne DH, Tso MO, Edward DP, Ripps H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology98, 602–607 (1991).
  • Chen H, Wu L, Pan S, Wu DZ. An immunologic study on age-related macular degeneration. Yen Ko Hsueh Pao (Eye Science)9, 113–120 (1993).
  • Gu X, Meer SG, Miyagi M et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem.278, 42027–42035 (2003).
  • Patel N, Ohbayashi M, Nugent AK et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology115, 422–430 (2005).
  • Cherepanoff S, Mitchell P, Wang JJ, Gillies MC. Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clin. Exp. Ophthalmol.34, 590–595 (2006).
  • Joachim SC, Grus FH, Pfeiffer N. Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur. J. Ophthalmol.13, 752–758 (2003).
  • Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N. Complex autoantibody repertoires in patients with glaucoma. Mol. Vis.10, 132–137 (2004).
  • Avrameas S, Ternynck T. Natural autoantibodies: the other side of the immune system. Res. Immunol.146, 235–248 (1995).
  • Wu KH, Madigan MC, Billson FA, Penfold PL. Differential expression of GFAP in early v late AMD: a quantitative analysis. Br. J. Ophthalmol.87, 1159–1166 (2003).
  • Augusteyn RC. α-crystallin: a review of its structure and function. Clin. Exp. Optometry87, 356–366 (2004).
  • Crabb JW, Miyagi M, Gu X et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl Acad. Sci. USA99, 14682–14687 (2002).
  • Aaronson RM, Graven KK, Tucci M, McDonald RJ, Farber HW. Non-neuronal enolase is an endothelial hypoxic stress protein. J. Biol. Chem.270, 27752–27757 (1995).
  • Gitlits VM, Toh BH, Sentry JW. Disease association, origin, and clinical relevance of autoantibodies to the glycolytic enzyme enolase. J. Invest. Med.49, 138–145 (2001).
  • Binder CJ, Shaw PX, Chang M-K et al. Thematic review series: the immune system and atherogenesis. The role of natural antibodies in atherogenesis. J. Lipid Res.46, 1353–1363 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.